What do Apple CEO Tim Cook, actress Jane Lynch, and Senator Amy Klobuchar have in common? They're just a few of the over 3.7 million Americans who will likely see their Social Security benefits reduced because they were born in 1960. If you were also born that year, you too cou
Many of us rely on a delicious cup of hot coffee to start our workday. Starbucks (NASDAQ: SBUX) does a great job of serving up that daily dose of caffeine, along with a growing selection of food items for breakfast and lunch. What many investors may not realize is that the compa
If you're like most people, you haven't socked away nearly enough for retirement. About half of people aged 35 to 44 have saved less than $25,000 for retirement, per the 2019 Retirement Confidence Survey. Among those 55 and older, 23% have saved less than $25,000. Yikes.
COVID-19 isn't going anywhere, not anytime soon at least. For investors, that means it's time to adapt and invest based on strategies that may be successful amid the pandemic. By holding investments in your portfolio that are able to do well even during adverse conditions like t
It's hard to describe Deere's (NYSE: DE) recent third-quarter earnings report as anything less than a "blowout." The company exceeded external and internal expectations, and the underlying development of the business suggests that the stock remains attractively priced. Let's tak
VPC Impact Acquisition Holdings, a blank check company formed by Victory Park Capital to acquire a fintech business, filed on Friday with the SEC to raise up to $200 million in an initial public offering.
The Chicago, IL-based company plans to raise $200 million by offering 20 mi
A strong August trading run has ended with two attention-grabbing stock splits. Tesla (NASDAQ: TSLA) and Apple caused outages on several popular trading platforms as investors rushed to buy up shares before enthusiasm carried the price higher.
A few weeks ago, top U.S. mall owners Simon Property Group (NYSE: SPG) and Brookfield Property Partners (NASDAQ: BPY) seemed to be closing in on a deal to buy J.C. Penney (OTC: JCPN.Q) out of bankruptcy. While retail-focused private equity firm Sycamore Partners had offered a sl
The years in your 50s are pivotal ages on the road to retirement. At this stage of life, you may be making plans for how you'll spend your senior years and when you'll close out your career. You might also be grappling with college tuition payments for your children or other exp
The coronavirus pandemic has wreaked havoc on the U.S. economy, and pushed the country's unemployment levels up to historic highs in a matter of months. Many businesses are still reeling from the effects of the virus, but some tech stocks have actually thrived during this time.
What happened
Shares of Carnival (NYSE: CCL) rose 18.7% in August, according to data from S&P Global Market Intelligence. The cruise line operator's stock was decimated earlier this year amid the COVID-19 pandemic, but has seen big spikes periodically throughout the spring
Defense stocks were a relative safe haven during COVID-19, with the Pentagon scrambling to keep assembly lines running and payments flowing during the lows of the pandemic.
It would be easy to think that the cannabis industry is in a state of malaise if you only looked at Canadian marijuana stocks. All of the biggest Canadian pot stocks are down year to date.
Investors in 2020 have witnessed two wild extremes crammed into about a six-month time frame. During the first quarter, panic and uncertainty surrounding the coronavirus disease 2019 (COVID-19) pandemic sent the broad-based S&P 500 screaming to its fastest and steepest bear-
If you think industrial assembly lines in the U.S. aren't running yet as the COVID-19 pandemic continues to rage, think again. The closely watched manufacturing index from the Institute for Supply Management (ISM) hit a 21-month high of 56% in August, reflecting a strong uptick
Nobody wants to think about stocks crashing in 2020 the way they did back in March, but the reality is that we just don't know what the pandemic has in store. If cases skyrocket, or there's bad news on the vaccine front, stocks could react negatively.
Moderna (NASDAQ: MRNA) has been one of the superstars of the coronavirus vaccine race -- from a share performance and vaccine development perspective. The biotech company's shares have soared as it went from first to start human trials to a phase 3 trial in about four months.